New Phosphorylation Sites of Rad51 by c-Met Modulates Presynaptic Filament Stability.
DNA repair
HGFR kinase
RAD51 recombinase
cancer outcomes
post-translational modification
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
23 Mar 2019
23 Mar 2019
Historique:
received:
15
02
2019
revised:
10
03
2019
accepted:
20
03
2019
entrez:
27
3
2019
pubmed:
27
3
2019
medline:
27
3
2019
Statut:
epublish
Résumé
Genomic instability through deregulation of DNA repair pathways can initiate cancer and subsequently result in resistance to chemo and radiotherapy. Understanding these biological mechanisms is therefore essential to overcome cancer. RAD51 is the central protein of the Homologous Recombination (HR) DNA repair pathway, which leads to faithful DNA repair of DSBs. The recombinase activity of RAD51 requires nucleofilament formation and is regulated by post-translational modifications such as phosphorylation. In the last decade, studies have suggested the existence of a relationship between receptor tyrosine kinases (RTK) and Homologous Recombination DNA repair. Among these RTK the c-MET receptor is often overexpressed or constitutively activated in many cancer types and its inhibition induces the decrease of HR. In this study, we show for the first time that c-MET is able to phosphorylate the RAD51 protein. We demonstrate in vitro that c-MET phosphorylates four tyrosine residues localized mainly in the subunit-subunit interface of RAD51. Whereas these post-translational modifications do not affect the presynaptic filament formation, they strengthen its stability against the inhibitor effect of the BRC peptide obtained from BRCA2. Taken together, these results confirm the role of these modifications in the regulation of the BRCA2-RAD51 interaction and underline the importance of c-MET in DNA damage response.
Identifiants
pubmed: 30909596
pii: cancers11030413
doi: 10.3390/cancers11030413
pmc: PMC6468871
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ligue Contre le Cancer
ID : Comité 44
Références
Nature. 2002 Nov 21;420(6913):287-93
pubmed: 12442171
J Biochem. 2003 May;133(5):593-7
pubmed: 12801910
EMBO J. 2003 Sep 1;22(17):4566-76
pubmed: 12941707
Mol Cell. 2003 Oct;12(4):1029-41
pubmed: 14580352
J Mol Biol. 2004 Jan 23;335(4):895-904
pubmed: 14698287
J Mol Biol. 2004 Jun 11;339(4):797-804
pubmed: 15165851
EMBO J. 2004 Oct 1;23(19):3721-34
pubmed: 15385963
Annu Rev Genet. 2004;38:233-71
pubmed: 15568977
Nat Cell Biol. 2005 Feb;7(2):195-201
pubmed: 15665856
Cancer Res. 2005 Feb 15;65(4):1479-88
pubmed: 15735036
DNA Repair (Amst). 2006 Mar 7;5(3):381-91
pubmed: 16388992
Genes Cells. 2006 May;11(5):513-24
pubmed: 16629903
Nat Struct Mol Biol. 2007 Jun;14(6):475-83
pubmed: 17515903
Int J Oncol. 2007 Jul;31(1):49-58
pubmed: 17549404
Nat Rev Genet. 2008 Jan;9(1):27-37
pubmed: 18040271
Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):692-7
pubmed: 18180459
Nucleic Acids Res. 2008 Jun;36(10):3226-34
pubmed: 18417535
Genes Cells. 2008 May;13(5):471-81
pubmed: 18429819
Carcinogenesis. 2009 Jun;30(6):937-45
pubmed: 19357348
FEBS Lett. 2009 Jun 18;583(12):1867-72
pubmed: 19427856
Nucleic Acids Res. 2010 Jan;38(1):82-96
pubmed: 19875419
Radiat Oncol. 2009 Dec 22;4:69
pubmed: 20028557
J Med Chem. 2010 Aug 12;53(15):5782-91
pubmed: 20684611
Biochimie. 2010 Dec;92(12):1832-8
pubmed: 20713120
Int J Cancer. 2012 Feb 1;130(3):728-34
pubmed: 21400509
Blood. 2011 Jul 28;118(4):1062-8
pubmed: 21653319
Mol Cell. 2012 Feb 10;45(3):371-83
pubmed: 22325354
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 May 1;68(Pt 5):511-6
pubmed: 22691778
PLoS One. 2013 Aug 12;8(8):e68784
pubmed: 23950876
Cancers (Basel). 2013 Dec 19;6(1):1-27
pubmed: 24378750
Int J Biochem Cell Biol. 2014 Apr;49:69-74
pubmed: 24440758
Biochem Pharmacol. 2014 Oct 1;91(3):293-300
pubmed: 25124703
Chemphyschem. 2014 Dec 1;15(17):3753-60
pubmed: 25208912
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15090-5
pubmed: 25288749
Biomolecules. 2015 Nov 20;5(4):3204-59
pubmed: 26610585
J Phys Chem B. 2016 Mar 10;120(9):2165-78
pubmed: 26890079
Dis Markers. 2016;2016:6594016
pubmed: 27069297
Proc Natl Acad Sci U S A. 2016 Oct 11;113(41):E6045-E6054
pubmed: 27671650
Nucleic Acids Res. 2017 May 5;45(8):4507-4518
pubmed: 28168276
Biochimie. 2017 Aug;139:115-124
pubmed: 28571978
EMBO J. 2018 Apr 3;37(7):
pubmed: 29507080
Cell. 1994 Apr 22;77(2):261-71
pubmed: 7513258
Nature. 1996 Nov 14;384(6605):173-6
pubmed: 8906793
Mutat Res. 1997 Aug;384(2):65-72
pubmed: 9298115
Nature. 1998 Jan 15;391(6664):285-8
pubmed: 9440692
J Biol Chem. 1998 Feb 13;273(7):3799-802
pubmed: 9461559
Cancer. 1998 Apr 15;82(8):1513-20
pubmed: 9554529